Page last updated: 2024-09-04

ivabradine and Nerve Pain

ivabradine has been researched along with Nerve Pain in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Baba, H; Ohashi, M; Ohashi, N; Uta, D1
Fuseya, S; Ishida, K; Ishida, T; Ito, M; Kawamata, M; Sakamoto, A; Tanaka, S1
Fuseya, S; Ishida, K; Kashihara, T; Kawagishi, H; Kawamata, M; Kiyosawa, K; Nakada, T; Tanaka, S; Yamada, M; Zhang, H1
Armstrong, G; Bond, S; Lee, MC; McNaughton, P; Menon, D; Scholtes, I; Wheeler, D1
Bukhanova, N; Chen, Y; Kumar, N; Noh, S; Smith, PA; Stemkowsi, PL1
Emery, EC; McNaughton, PA; Mooney, ER; Tsantoulas, C; Young, GT1

Trials

2 trial(s) available for ivabradine and Nerve Pain

ArticleYear
A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers.
    Scientific reports, 2022, 10-14, Volume: 12, Issue:1

    Topics: Adult; Analgesics; Calcium Channel Blockers; Capsaicin; Cross-Over Studies; Female; Healthy Volunteers; Humans; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Neuralgia; Nucleotides, Cyclic

2022
A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial.
    Pain, 2019, Volume: 160, Issue:11

    Topics: Analgesics; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Heart Rate; Hyperalgesia; Ivabradine; Neuralgia

2019

Other Studies

4 other study(ies) available for ivabradine and Nerve Pain

ArticleYear
Analgesic effect of ivabradine against inflammatory pain mediated by hyperpolarization-activated cyclic nucleotide-gated cation channels expressed on primary afferent terminals in the spinal dorsal horn.
    Pain, 2022, 07-01, Volume: 163, Issue:7

    Topics: Analgesics; Animals; Cations; Cyclic Nucleotide-Gated Cation Channels; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Nerve Fibers, Unmyelinated; Neuralgia; Rats; Spinal Cord Dorsal Horn

2022
Prostanoid EP4 Receptor-Mediated Augmentation of
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 368, Issue:1

    Topics: Animals; Dose-Response Relationship, Drug; Ganglia, Spinal; Injections, Spinal; Ivabradine; Male; Membrane Potentials; Neuralgia; Neurons; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides

2019
The heart-rate-reducing agent, ivabradine, reduces mechanical allodynia in a rodent model of neuropathic pain.
    European journal of pain (London, England), 2014, Volume: 18, Issue:8

    Topics: Analgesics; Animals; Arterial Pressure; Benzazepines; Disease Models, Animal; Female; Heart Rate; Hyperalgesia; Ivabradine; Male; Neuralgia; Pain Measurement; Pain Threshold; Peripheral Nerve Injuries; Rats; Rats, Sprague-Dawley

2014
Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels.
    Pain, 2014, Volume: 155, Issue:9

    Topics: Animals; Benzazepines; Cells, Cultured; Female; Ganglia, Spinal; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Inflammation; Ivabradine; Male; Membrane Potentials; Mice; Neuralgia; Neurons; Patch-Clamp Techniques

2014